Holen Sie sich die Stockscreener-App
74.77
0.99%
0.73
Schlusskurs vom Vortag:
$74.04
Offen:
$74.05
24-Stunden-Volumen:
489.92K
Relative Volume:
0.89
Marktkapitalisierung:
$3.59B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$123.81M
KGV:
31.02
EPS:
2.41
Netto-Cashflow:
$20.35M
1W Leistung:
-0.57%
1M Leistung:
-2.03%
6M Leistung:
+8.28%
1J Leistung:
-17.04%
1-Tages-Spanne:
$73.48
$75.03
1-Wochen-Bereich:
$73.48
$76.67
52-Wochen-Spanne:
$55.30
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Branche
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
74.77 | 3.56B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-26 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Is Haemonetics Corporation stock a growth or value playFree Weekly Setup With 3x Return Potential - Newser
Why Haemonetics Corporation stock attracts strong analyst attentionSector Rotation Outlook With Historical Summary - Newser
Using data models to predict Haemonetics Corporation stock movementFree Accurate Buy Point for Momentum Stocks - Newser
What makes Haemonetics Corporation stock attractive to long term investorsPattern Recognition Based Market Move Prediction - Newser
What to expect from Haemonetics Corporation in the next 30 daysReal Time Growth Signal with Smart Setup - Newser
Will Haemonetics Corporation see short term momentumFast Entry Strategy with Price Prediction - Newser
Haemonetics Corporation Stock Poised for Technical ComebackBeginner Friendly Stock Selection Guide Updated - metal.it
Is Haemonetics Corporation reversing from oversold territoryControlled Entry Strategy With Safety Analytics - Newser
What makes Haemonetics Corporation stock price move sharplyAI Pattern Recognition and Trade Prediction - Newser
Why Haemonetics Corporation is moving todayRisk Adjusted Trade Signal Screening Tool - Newser
Should you hold or exit Haemonetics Corporation now Smart Safety Strategy With Real Data Analysis - Newser
Does Haemonetics Corporation stock perform well during market downturnsAccelerated profit realization - jammulinksnews.com
Is it the right time to buy Haemonetics Corporation stockDynamic growth stocks - jammulinksnews.com
Haemonetics Builds Momentum with New Buy Rating and Growth Promise - Insider Monkey
Envestnet Asset Management Inc. Has $3.54 Million Stake in Haemonetics Corporation (NYSE:HAE) - Defense World
Haemonetics Holds Successful Annual Shareholders Meeting - The Globe and Mail
What analysts say about Haemonetics Corporation stockConsistently high yield - Autocar Professional
Haemonetics Corporation Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com
What drives Haemonetics Corporation stock priceTriple-digit return opportunities - jammulinksnews.com
Mutual of America Capital Management LLC Has $1.64 Million Stock Holdings in Haemonetics Corporation (NYSE:HAE) - Defense World
Is Haemonetics Corporation a good long term investmentHigh-margin investment plays - jammulinksnews.com
M&T Bank Corp Acquires Shares of 3,812 Haemonetics Corporation (NYSE:HAE) - Defense World
Nisa Investment Advisors LLC Has $50,000 Position in Haemonetics Corporation (NYSE:HAE) - Defense World
How Haemonetics Corporation stock performs during market volatilityHigh Win Rate Stock Ideas - Newser
Therapeutic Plasma Exchange Market Size, Growth Insights - openPR.com
Platelet Aggregation Devices Market Set to Witness Significant - openPR.com
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know - Yahoo Finance
Haemonetics Announces Q1 FY26 Earnings Release and Conference Call - AInvest
Haemonetics Shares Rise After Upgrade From Citigroup - MarketScreener
Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes - Investing.com
Citigroup Upgrades Haemonetics to Buy From Neutral, Lifts Price Target to $90 From $71 - MarketScreener
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):